Navigation Links
Rigel Announces First Quarter 2012 Financial Results
Date:5/1/2012

coid lupus in the next few months," said James M. Gower, chairman and chief executive officer of Rigel.

About Rigel (www.rigel.com)

Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. Rigel's pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market its product candidates. Current product development programs include: fostamatinib, an oral SYK inhibitor that is in Phase 3 clinical trials for rheumatoid arthritis with Rigel's collaboration partner AstraZeneca; R343, an inhaled SYK inhibitor that has completed Phase 1 clinical trials for asthma; R333, a topical JAK/SYK inhibitor for discoid lupus; and R548, an oral JAK3 inhibitor for the treatment of transplant rejection and other immune disorders.

This press release contains "forward-looking" statements, including, without limitation, statements related to Rigel's future product candidate pipeline and strategy, the potential uses and efficacy of Rigel's product candidates, the progress of Rigel's product development programs, including the timing of commencement and results thereof, the timing and design of its future clinical trials and potential milestones and regulatory filings associated with Rigel's product candidates, Rigel's corporate collaborations, and revenues that may be received from collaborations and the timing of those potential payments, and the future expected amount and sufficiency of Rigel's cash resources. Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Words such as  "plan," "expect,"
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
2. Rigels R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study
3. Rigel Announces Initiation of Phase 1 Clinical Trial of R348 for Rheumatoid Arthritis, Psoriasis and Other Immune Disorders
4. Rigels R788 Shows Preclinical Activity in Type 1 Diabetes Model
5. Rigels R788 Slows Progression of Murine Lupus in Preclinical Studies
6. Rigel to Host Conference Call to Discuss Preliminary Phase 2 Study Results of R788 in Lymphoma
7. Rigels R788 Phase 2a Results Published in Arthritis and Rheumatism
8. Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results
9. Shareholder Class Action Filed Against Rigel Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
10. Rigel Commences Phase 2 Trial of R788 in Peripheral T-Cell Lymphomas
11. Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi2 Clinical Trial of R788 in Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... 20, 2014 /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: CMN ) ... Officer, will be presenting at the 26 th Annual ... in New York . The formal presentation ... ET. In addition, Mr. Krakauer and Jorgen B. Hansen ... meetings during the day. An audio webcast ...
(Date:11/21/2014)... QC , Nov. 20, 2014 /CNW Telbec/ - ... to announce the following appointments: ... team in the newly created role of Chief Commercial ... BioPhotonic system using topical photoconverter gel for the treatment ... surgical and traumatic wounds, recently approved in ...
(Date:11/21/2014)... Texas , 21. November 2014 ... was sich am Morgen des 14. Februar 2014 zugetragen ... jedoch wohl kaum vergessen. Video - ... dass ich dabei war, mein morgendliches Training zu machen", ... waren zu der Zeit begeisterte Anhänger der ...
Breaking Medicine Technology:KLOX Technologies announces executive appointments 2KLOX Technologies announces executive appointments 3KLOX Technologies announces executive appointments 4Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 2Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 3
... China , April 22 /PRNewswire-Asia-FirstCall/ -- ... "the Company"),a Xianyang-based manufacturer of a leading over-the-counter ... Aoxing"), and a variety of,pharmaceutical products, today announced ... its common stock on the NASDAQ Global Market. ...
... Boehringer Ingelheim Pharmaceuticals, Inc. and Connecticut United for Research Excellence, ... a comprehensive initiative designed to bring hands-on science education directly to ... , , , ... of the effort is the Boehringer Ingelheim Science Quest mobile laboratory ...
Cached Medicine Technology:Biostar Pharmaceuticals Approved for Listing on NASDAQ Global Market 2Biostar Pharmaceuticals Approved for Listing on NASDAQ Global Market 3Biostar Pharmaceuticals Approved for Listing on NASDAQ Global Market 4New Boehringer Ingelheim Science Quest Mobile Laboratory Brings Hands-On Science Education to Priority Connecticut Elementary Schools 2New Boehringer Ingelheim Science Quest Mobile Laboratory Brings Hands-On Science Education to Priority Connecticut Elementary Schools 3New Boehringer Ingelheim Science Quest Mobile Laboratory Brings Hands-On Science Education to Priority Connecticut Elementary Schools 4New Boehringer Ingelheim Science Quest Mobile Laboratory Brings Hands-On Science Education to Priority Connecticut Elementary Schools 5
(Date:11/23/2014)... 2014 BambooFlooringChina.com , the world’s leader ... strand woven bamboo flooring collection. Now, the business is ... company’s CEO, the promotion is valid until Dec. 20, 2014. ... a smooth and dust-free surface, which makes it very easy ... industry, the company wants to make its website the best ...
(Date:11/22/2014)... Every year AlignLife clinics nationwide team together to ... in the Greenville, SC area in 2014 and has ... Simpsonville will be partnering with the 5 other ... Drive. These six offices came together to decide on ... toy drive. With so many amazing organizations to choose ...
(Date:11/22/2014)... (PRWEB) November 23, 2014 Cancer researchers ... a connection between intercellular communication tunnels and the growth ... the full story on the Surviving Mesothelioma website. ... and the University of Minnesota have just released their ... information and materials between cells. They found that ...
(Date:11/22/2014)... Recently, UWDress.com, a successful wedding dress shop, has released ... in order to prepare for the wedding season. All of ... , UWDress.com is a reliable company that has many ... new items -- formal wedding guest attire. This new collection ... superstar and princess. As one of the leading companies in ...
(Date:11/22/2014)... Recently, Locks-Magnetic.com , one of ... promotion of mag locks for glass doors online. In ... on these fresh products. Customers can get more information ... doors are in excellent performance. Customers who want to ... soon as possible. They also can enjoy the ...
Breaking Medicine News(10 mins):Health News:Click Strand Woven Bamboo Flooring From Famous Bamboo Flooring Company BambooFlooringChina.com 2Health News:Greenville Area AlignLife Offices Join Together for a Local Toy Drive 2Health News:Study Links Cellular ‘Tunnels’ to Mesothelioma Proliferation, According to Surviving Mesothelioma 2Health News:Formal Wedding Guest Attire Added to UWDress.com 2Health News:Discounted Mag Locks for Glass Doors Revealed by Locks-Magnetic.com 2
... Louis, June 19, 2008 As if the emotional ... floodwaters can also bring health problems. H. James Wedner, ... of Allergy and Immunology at Washington University School of ... damp homes and businesses are fertile grounds for mold ...
... A Life By What We Give is the title of a ... and how they can share what they have to improve their ... for Children physician-philosopher Richard B. Gunderman, M.D., Ph.D. guides readers through ... lives. , In the book, Dr. Gunderman expands on the adage, ...
... Agency Agrees to Additional Protections for Poor Beneficiaries, ... a settlement,agreement filed in federal court today in ... Leavitt, the Bush administration has agreed to make,significant ... benefit,for low-income beneficiaries. If approved by the judge, ...
... to Identify, Develop and Empower Local ... as Honorary Chairman, PRINCETON, N.J., June 19 Building ... to build a grassroots network across,the state to identify, develop ... Majority will be the development of local, county,and statewide candidates. ...
... Integrated Behavioral Health,(IBH) has selected BlueThread Technologies, ... Server-based enterprise content management,(ECM) solutions and K2 ... and optimize claims processing., IBH processes ... of the Fortune,100 companies, 6,000 mid-to-small-sized employers ...
... organism heavily relied upon for studying basic biological processes ... distinctly different pattern than other model organisms, a finding ... evolutionary genetics in human diseases and cancer. The study, ... University, Harvard University, and the University of Utah, appears ...
Cached Medicine News:Health News:Allergy expert has advice for flood victims 2Health News:Allergy expert has advice for flood victims 3Health News:Bush Administration Settles Nationwide Class Action in Medicare Prescription Drug Case 2Health News:Bush Administration Settles Nationwide Class Action in Medicare Prescription Drug Case 3Health News:'Building the New Majority' Launches Grassroots GOP Effort in New Jersey 2Health News:Integrated Behavioral Health Optimizes Claims Processing With BlueThread's SmartDesk, K2 Workflow and Microsoft Office SharePoint Server 2Health News:Integrated Behavioral Health Optimizes Claims Processing With BlueThread's SmartDesk, K2 Workflow and Microsoft Office SharePoint Server 3Health News:New research on mutation in yeast can enhance understanding of human diseases 2
Smooth colibri tip; In Titanium....
Straight Shafts with 0.2mm 1X2 Teeth, 5mm Tying Platform; In Titanium....
Gently curved 5mm Platform With 12, 0.12mm Teeth; In Titanium....
Curved Shaft with 5mm Platform; 1x2, 0.12 mm teeth; In Titanium....
Medicine Products: